Order Entry
ContactUsLinkComponent
Hemoglobin S Control Peptide
Hemoglobin S Control Peptide
Catalog #: 76222-538
CAS Number:  
Hemoglobin S Control Peptide
Catalog #: 76222-538
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.

Specifications

  • Size:
    50 µg
  • Protein/peptide name:
    Hemoglobin S Control Peptide
  • Shipping temperature:
    Ambient
  • Tested applications:
    Control Peptide
  • Cat. no.:
    76222-538

Specifications

About this item

Hemoglobin S Control Peptide

  • Control Peptide - Blocking Peptide
  • PCA Assays
  • ImmunoBlot

HbS peptide corresponds to the E6V mutant in the hemoglobin beta subunit. Functional adult hemoglobin (Hb) is a hetero tetramer composed of 2 alpha and 2 beta subunits (α2β2). Common isoform variants of hemoglobin include HbA, HbS, HbC, HbF, and HbA2. Hemoglobin S is the predominant hemoglobin in people with sickle cell disease. The alpha chain is normal. The disease-producing mutation exists in the beta chain, giving the molecule the structure, α2βS2. People who have one sickle mutant gene and one normal beta gene have sickle cell trait which is benign. Globin gene mutations affect the structure and expression levels of Hb. Sickle cell disease and the more benign sickle cell trait are observed in more than 100 million people globally. Perhaps the most significant mutation is the E6V in the beta subunit and the cause of SCD, but other relevant isoforms of Hb are observed. HbS peptide may be used as a control with anti-HbS antibody. This peptide is ideal for investigators involved in Cardiovascular and developmental biology research.

HbS peptide can be used as a control with the HbS antibody. Control peptide should be used at 1.0 µg per 1.0 µl of antiserum in per assay.

Customers Who Bought This Also Bought